Medical News on Cancer
FDA approves first-line use of Vectibix® (panitumumab) plus FOLFOX for patients with wild-type KRAS metastatic colorectal cancer
May 28, 2014
Amgen has announced that the U.S. Food and Drug Administration (FDA) has approved Vectibix® (panitumumab) for use in combination with FOLFOX, an oxaliplatin-based chemotherapy regimen, as... Read More
Immunotherapy for prostate cancer in sight
May 27, 2014
An international study carried out with involvement of the MedUni Vienna is giving hope to patients with advanced prostate cancer. Read More
New insight into inflammatory bowel diseases offered by wound-healing role of microRNAs in colon
May 27, 2014
A microRNA cluster believed to be important for suppressing colon cancer has been found to play a critical role in wound healing in the intestine, UT Southwestern cancer researchers have found. Read More
Promising results from clinical trials designed to block autophagy in multiple cancers
May 27, 2014
In the largest group of results to date, researchers from Penn Medicine's Abramson Cancer Center and other institutions have shown in clinical trials that the malaria drug hydroxychloroquine (HCQ)... Read More
Understanding of how Taxol works could lead to better anticancer drugs
May 25, 2014
University of California, Berkeley, scientists have discovered the extremely subtle effect that the prescription drug Taxol has inside cells that makes it one of the most widely used anticancer... Read More
Image fusion-guided biopsy improves accuracy of prostate cancer diagnosis
May 24, 2014
A recent study by investigators from LIJ Medical Center demonstrated that using magnetic resonance imaging (MRI) in men with an elevated prostate specific antigen (PSA) resulted in a prostate cancer... Read More
How streptococcal bacteria can be used to fight colon cancer
May 22, 2014
Researchers at Western University (London, Canada) have shown how the bacteria primarily responsible for causing strep throat can be used to fight colon cancer. Read More
Prolaris® test predicts mortality risk in prostate cancer biopsy study
May 21, 2014
Myriad Genetics, Inc. has presented new data from a clinical validation study of Prolaris at the 2014 American Urological Association (AUA) Annual Meeting in Orlando, Fla. Read More
Metabolic syndrome disorders, diet may boost prostate cancer risk
May 21, 2014
Three new studies featuring the impact of dietary and lifestyle factors on prostate cancer were presented during the 109th Annual Scientific Meeting of the American Urological Association (AUA). Read More
New biopsy method more accurately identifies men at low risk for prostate cancer
May 21, 2014
More and more men who believe they have low-risk prostate cancers are opting for active surveillance, forgoing treatment and monitoring the cancer closely with prostate-specific antigen (PSA) tests... Read More
Previous Page Next Page